Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-03-18 Sale |
2021-03-22 4:59 pm |
GenMark Diagnostics Inc. | GNMK | Jensen Tyler SVP, Engineering and Tech Dev |
500 | $23.88 | $11,940 | 211,888 (Direct) |
View |
2021-03-04 Sale |
2021-03-08 5:33 pm |
GenMark Diagnostics Inc. | GNMK | Jensen Tyler SVP, Engineering and Tech Dev |
500 | $18.86 | $9,430 | 212,388 (Direct) |
View |
2021-03-05 Sale |
2021-03-08 5:32 pm |
GenMark Diagnostics Inc. | GNMK | Shaw Christine VP, Assay Development |
274 | $18.56 | $5,085 | 102,196 (Direct) |
View |
2021-03-01 Sale |
2021-03-01 5:54 pm |
GenMark Diagnostics Inc. | GNMK | Maderazo Alan Baer VP, Qual, Reg, & Clin Affairs |
2,127 | $19.19 | $40,817 | 262,180 (Direct) |
View |
2021-02-26 Sale |
2021-03-01 5:51 pm |
GenMark Diagnostics Inc. | GNMK | Gleeson Michael SVP, Corp. Accounts |
17,750 | $17.01 | $301,928 | 422,812 (Indirect Direct) |
View |
2021-02-26 Sale |
2021-03-01 5:50 pm |
GenMark Diagnostics Inc. | GNMK | Harkins Michael John SVP, Sales |
12,381 | $17.03 | $210,848 | 143,611 (Direct) |
View |
2021-02-26 Sale |
2021-03-01 5:49 pm |
GenMark Diagnostics Inc. | GNMK | Winkler Sarah Hollis VP, Human Resources |
11,181 | $17.01 | $190,189 | 147,502 (Direct) |
View |
2021-02-26 Sale |
2021-03-01 5:48 pm |
GenMark Diagnostics Inc. | GNMK | Shaw Christine VP, Assay Development |
3,151 | $17.03 | $53,662 | 102,470 (Direct) |
View |
2021-02-25 Sale |
2021-02-25 6:33 pm |
GenMark Diagnostics Inc. | GNMK | Maderazo Alan Baer VP, Qual, Reg, & Clin Affairs |
266 | $19.16 | $5,097 | 278,253 (Direct) |
View |
2021-02-23 Sale |
2021-02-25 6:32 pm |
GenMark Diagnostics Inc. | GNMK | Gleeson Michael SVP, Corp. Accounts |
3,895 | $19.2 | $74,802 | 440,562 (Indirect Direct) |
View |
2021-02-23 Sale |
2021-02-25 6:32 pm |
GenMark Diagnostics Inc. | GNMK | Shaw Christine VP, Assay Development |
425 | $19.21 | $8,164 | 105,621 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-04-22 Equity Swap |
2021-04-22 1:55 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | Giles Lisa M. Director |
87,072 | $24.05 | 0 (Direct) |
View |
2021-04-22 Equity Swap |
2021-04-22 1:55 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | Kagnoff Michael Director |
137,319 | $24.05 | 0 (Direct) |
View |
2021-04-22 Equity Swap |
2021-04-22 1:55 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | Fox James Director |
263,102 | $24.05 | 0 (Direct) |
View |
2021-04-22 Equity Swap |
2021-04-22 1:54 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | FAULKNER DARYL Director |
133,871 | $24.05 | 0 (Direct) |
View |
2021-04-22 Equity Swap |
2021-04-22 1:54 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | OBOYLE KEVIN C Director |
131,678 | $24.05 | 0 (Direct) |
View |
2021-04-22 Equity Swap |
2021-04-22 1:54 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | Stevenson Wade R. SVP, North America Sales |
50,000 | $24.05 | 0 (Direct) |
View |
2021-04-22 Equity Swap |
2021-04-22 1:53 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | Shaw Christine VP, Assay Development |
101,324 | $24.05 | 0 (Direct) |
View |
2021-04-22 Equity Swap |
2021-04-22 1:53 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | Winkler Sarah Hollis VP, Human Resources |
147,502 | $24.05 | 0 (Direct) |
View |
2021-04-22 Equity Swap |
2021-04-22 1:52 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | Maderazo Alan Baer VP, Qual, Reg, & Clin Affairs |
262,180 | $24.05 | 0 (Direct) |
View |
2021-04-22 Equity Swap |
2021-04-22 1:51 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | Jensen Tyler SVP, Engineering and Tech Dev |
212,249 | $24.05 | 0 (Direct) |
View |
2021-04-22 Equity Swap |
2021-04-22 1:51 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | O'Brien Scott Alexander SVP, Global Mktg & Int'l Sales |
170,879 | $24.05 | 0 (Direct) |
View |
2021-04-22 Equity Swap |
2021-04-22 1:51 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | Chohan Abdul SVP Operations |
63,750 | $24.05 | 0 (Direct) |
View |
2021-04-22 Equity Swap |
2021-04-22 1:50 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | Stier Eric SVP & General Counsel |
275,974 | $24.05 | 0 (Direct) |
View |
2021-04-22 Equity Swap |
2021-04-22 1:50 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | Harkins Michael John SVP, Sales |
144,214 | $24.05 | 0 (Direct) |
View |
2021-04-22 Equity Swap |
2021-04-22 1:50 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | Gleeson Michael SVP, Corp. Accounts |
451,452 | $24.05 | 0 (Direct) |
View |
2021-04-22 Equity Swap |
2021-04-22 1:49 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer |
232,993 | $24.05 | 0 (Direct) |
View |
2021-04-22 Equity Swap |
2021-04-22 1:49 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | Mendel Scott President & CEO |
622,689 | $24.05 | 0 (Direct) |
View |
2021-04-14 Exercise |
2021-04-16 4:38 pm |
2017-03-06 2023-03-06 |
GenMark Diagnostics Inc. | GNMK | Gleeson Michael SVP, Corp. Accounts |
12,787 | $10.89 | 468,587 (Direct) |
View |
2021-04-14 Exercise |
2021-04-16 4:38 pm |
2019-02-19 2025-02-19 |
GenMark Diagnostics Inc. | GNMK | Gleeson Michael SVP, Corp. Accounts |
4,926 | $13.17 | 468,587 (Direct) |
View |
2021-04-14 Exercise |
2021-04-16 4:38 pm |
2018-03-06 2024-03-06 |
GenMark Diagnostics Inc. | GNMK | Gleeson Michael SVP, Corp. Accounts |
9,954 | $12.3 | 468,587 (Direct) |
View |
2021-04-09 Option Award |
2021-04-12 6:00 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | Stevenson Wade R. SVP, North America Sales |
50,000 | $0 | 50,000 (Direct) |
View |
2021-04-01 Tax Withholding |
2021-04-06 6:00 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | Shaw Christine VP, Assay Development |
1,730 | $0 | 100,466 (Direct) |
View |
2021-03-04 Tax Withholding |
2021-03-08 5:33 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | O'Brien Scott Alexander SVP, Global Mktg & Int'l Sales |
735 | $0 | 170,879 (Direct) |
View |
2021-02-25 Tax Withholding |
2021-03-01 5:54 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | Maderazo Alan Baer VP, Qual, Reg, & Clin Affairs |
13,946 | $0 | 262,180 (Direct) |
View |
2021-02-25 Tax Withholding |
2021-03-01 5:53 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | Stier Eric SVP & General Counsel |
14,642 | $0 | 275,974 (Direct) |
View |
2021-02-25 Tax Withholding |
2021-03-01 5:53 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | Mendel Scott President & CEO |
41,834 | $0 | 622,689 (Direct) |
View |
2021-02-25 Tax Withholding |
2021-03-01 5:52 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | Ek John Frederick Chief Financial Officer |
19,248 | $0 | 232,993 (Direct) |
View |
2021-02-25 Tax Withholding |
2021-03-01 5:51 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | O'Brien Scott Alexander SVP, Global Mktg & Int'l Sales |
9,726 | $0 | 171,614 (Direct) |
View |
2021-02-25 Tax Withholding |
2021-03-01 5:51 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | Jensen Tyler SVP, Engineering and Tech Dev |
16,734 | $0 | 212,888 (Direct) |
View |
2021-02-23 Tax Withholding |
2021-02-25 6:34 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | Stier Eric SVP & General Counsel |
2,208 | $0 | 290,616 (Direct) |
View |
2021-02-23 Tax Withholding |
2021-02-25 6:33 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | Maderazo Alan Baer VP, Qual, Reg, & Clin Affairs |
1,744 | $0 | 278,253 (Direct) |
View |
2021-02-23 Tax Withholding |
2021-02-25 6:33 pm |
N/A N/A |
GenMark Diagnostics Inc. | GNMK | Mendel Scott President & CEO |
3,254 | $0 | 664,523 (Direct) |
View |